Osteoporotic fracture guideline
This guideline was developed by a multidisciplinary expert panel: Cooper C et al with the support of a grant from UCB Pharma Ltd.
NICE delirium guideline
This summary covers risk factor assessment, diagnosis, indicators of delirium, interventions to prevent delirium, and treatment.
Medication management of patients with enteral feeding tubes
This guideline was developed by a multidisciplinary expert panel: Wright D et al with the support of a grant from Rosemont Pharmaceuticals Ltd.
Type 2 diabetes: frailty in older people
Summary covers glycaemic targets for older people, priorities for improving high-quality diabetes care, and a useful frailty assessment pathway.
SCIE indicators of abuse guideline
This insightful summary explores the forms that abuse can take, and the signs or possible indicators that may suggest a person is experiencing abuse.
PHE herpes zoster guideline
This summarises Public Health England's shingles (herpes zoster) immunisation policy.
SIGN stroke and dysphagia guideline
This summarises SIGN's guideline on the identification and management of dysphagia in stroke patients.
Fit for frailty guideline
A practical guideline summary for the recognition, assessment, and management of frailty in individuals in community and outpatient settings.
NICE older people wellbeing guideline
This summarises NICE's guideline on interventions to maintain and improve the mental wellbeing and independence of people aged 65 years or older.
BGS/BPS management of pain in older people guideline
A brief guideline summary on the management of pain in older people, with treatment algorithm that includes pharmacological and psychological approaches.
Educational resources
Osteoporotic fracture guideline
This guideline was developed by a multidisciplinary expert panel: Cooper C et al with the support of a grant from UCB Pharma Ltd.
Medication management of patients with enteral feeding tubes
This guideline was developed by a multidisciplinary expert panel: Wright D et al with the support of a grant from Rosemont Pharmaceuticals Ltd.